title: Precision Subtypes of T Cell-Mediated Rejection Identified by Molecular Profiles.
abstract: Among kidney transplant recipients, the treatment of choice for acute T cell-mediated rejection (TCMR) with pulse steroids or antibody protocols has variable outcomes. Some rejection episodes are resistant to an initial steroid pulse, but respond to subsequent antibody protocols. The biological mechanisms causing the different therapeutic responses are not currently understood. Histological examination of the renal allograft is considered the gold standard in the diagnosis of acute rejection. The Banff Classification System was established to standardize the histopathological diagnosis and to direct therapy. Although widely used, it shows variability among pathologists and lacks criteria to guide precision individualized therapy. The analysis of the transcriptome in allograft biopsies, which we analyzed in this study, provides a strategy to develop molecular diagnoses that would have increased diagnostic precision and assist the development of individualized treatment. Our hypothesis is that the histological classification of TCMR contains multiple subtypes of rejection. Using R language algorithms to determine statistical significance, multidimensional scaling, and hierarchical, we analyzed differential gene expression based on microarray data from biopsies classified as TCMR. Next, we identified KEGG functions, protein-protein interaction networks, gene regulatory networks, and predicted therapeutic targets using the integrated database ConsesnsusPathDB (CPDB). Based on our analysis, two distinct clusters of biopsies termed TCMR01 and TCMR02 were identified. Despite having the same Banff classification, we identified 1933 differentially expressed genes between the two clusters. These genes were further divided into three major groups: a core group contained within both the TCMR01 and TCMR02 subtypes, as well as genes unique to TCMR01 or TCMR02. The subtypes of TCMR utilized different biological pathways, different regulatory networks and were predicted to respond to different therapeutic agents. Our results suggest approaches to identify more precise molecular diagnoses of TCMR, which could form the basis for personalized treatments.
authors.affiliation: Finn-Perkins Laboratory, Department of Medicine, University of Illinois-Chicago , Chicago, IL , USA.
authors.forename: Paul Ostrom
authors.initials: PO
authors.lastname: Kadota
authors.affiliation: Finn-Perkins Laboratory, Department of Internal Medicine, Division of Nephrology, University of Illinois-Chicago , Chicago, IL , USA.
authors.forename: Zahraa
authors.initials: Z
authors.lastname: Hajjiri
authors.affiliation: Department of Medicine, University of Illinois-Chicago , Chicago, IL , USA.
authors.forename: Patricia W
authors.initials: PW
authors.lastname: Finn
authors.affiliation: Department of Medicine, University of Illinois-Chicago , Chicago, IL , USA ; Department of Surgery, University of Illinois-Chicago , Chicago, IL , USA.
authors.forename: David L
authors.initials: DL
authors.lastname: Perkins
keywords: TCMR; kidney transplant; personalized medicine; precision medicine; systems biology